↓ Skip to main content

Cochrane Database of Systematic Reviews

Peginterferon alpha‐2a versus peginterferon alpha‐2b for chronic hepatitis C

Overview of attention for article published in Cochrane database of systematic reviews, February 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (89th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (59th percentile)

Mentioned by

twitter
22 X users
googleplus
1 Google+ user
f1000
1 research highlight platform

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
170 Mendeley
Title
Peginterferon alpha‐2a versus peginterferon alpha‐2b for chronic hepatitis C
Published in
Cochrane database of systematic reviews, February 2014
DOI 10.1002/14651858.cd005642.pub3
Pubmed ID
Authors

Goran Hauser, Tahany Awad, Kristian Thorlund, Davor Štimac, Mahasen Mabrouk, Christian Gluud

Abstract

A combination of weekly pegylated interferon (peginterferon) alpha and daily ribavirin still represents standard treatment of chronic hepatitis C infection in the majority of patients. However, it is not established which of the two licensed peginterferon products, peginterferon alpha-2a or peginterferon alpha-2b, is the most effective and has a better safety profile.

X Demographics

X Demographics

The data shown below were collected from the profiles of 22 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 170 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 170 100%

Demographic breakdown

Readers by professional status Count As %
Student > Master 26 15%
Student > Ph. D. Student 22 13%
Student > Bachelor 18 11%
Student > Doctoral Student 13 8%
Researcher 12 7%
Other 25 15%
Unknown 54 32%
Readers by discipline Count As %
Medicine and Dentistry 54 32%
Nursing and Health Professions 18 11%
Psychology 8 5%
Biochemistry, Genetics and Molecular Biology 5 3%
Economics, Econometrics and Finance 5 3%
Other 21 12%
Unknown 59 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 July 2016.
All research outputs
#2,517,267
of 25,806,080 outputs
Outputs from Cochrane database of systematic reviews
#5,075
of 13,140 outputs
Outputs of similar age
#24,425
of 236,570 outputs
Outputs of similar age from Cochrane database of systematic reviews
#96
of 239 outputs
Altmetric has tracked 25,806,080 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,140 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.9. This one has gotten more attention than average, scoring higher than 61% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 236,570 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 239 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 59% of its contemporaries.